| Literature DB >> 35845676 |
Yupeng Fan1,2, Zhengmin Tang1, Junmei Wei1, Xiaoman Yu1, Huihui Guo1, Tongtong Li1, Haixia Guo1, Li Zhang1, Yijie Fan1, Changyu Zhang1, Fanchang Zeng1.
Abstract
Plant somatic cells can reprogram into differentiated embryos through somatic embryogenesis (SE) on the condition of plant growth regulators (PGRs). RNA sequencing analysis was performed to investigate transcriptional profiling on cotton redifferentiated callus that was induced by different auxin types (IAA and 2,4-D), different concentrations (0, 0.025, and 0.05 mg L-1), and different incubation times (0, 5, and 20 days). Under the 2,4-D induction effect, signal transduction pathways of plant hormones were significantly enriched in the embryogenic response stage (5 days). These results indicated that auxin signal transduction genes were necessary for the initial response of embryogenic differentiation. In the pre-embryonic initial period (20 days), the photosynthetic pathway was significantly enriched. Most differentially expressed genes (DEGs) were downregulated under the induction of 2,4-D. Upon the dose effect of IAA and 2,4-D, respectively, pathways were significantly enriched in phenylpropanoid biosynthesis, fatty acid metabolism, and carbon metabolic pathways. Therefore, primary and secondary metabolism pathways were critical in cotton SE. These results showed that complex synergistic mechanisms involving multiple cellular pathways were the causes of the induction and dose effect of auxin-induced SE. This study reveals a systematic molecular response to auxin signals and reveals the way that regulates embryogenic redifferentiation during cotton SE.Entities:
Keywords: 2; 4-D); 4-dichlorophenoxyacetic acid (2; cotton; dose effect; embryogenic induction effect; embryogenic redifferentiation; indole acetic acid (IAA); somatic embryogenesis; transcriptional regulation
Year: 2022 PMID: 35845676 PMCID: PMC9278894 DOI: 10.3389/fpls.2022.931105
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 6.627
Primer sequence for qRT-PCR.
|
|
|
|
|---|---|---|
|
| Basic endochitinase | AGCAGGAGAAGCAATAAAGG/ATGACACCGTATCCAGGGAC |
|
| Calcineurin B-like protein 4 | TCTTGCTGCTGAAACACCT/TCTAACGAACTCACCGAAC |
|
| Peroxidase 73 | GCAACTATCCGCCTCTTCT/GCTTAACCCATCCAACCTC |
|
| Cytochrome P450 82A3 | CTTTGGTAGTGGTAGGAGGAG/GAGCAAGACGAGGTGAGAC |
|
| Auxin response factor 4 | CAACATGAATCAAGCACCCAA/GTTTCCTGATGTCGTCCAC |
|
| Auxin-induced protein 22 | GGCAACTCTTCGGAGCAAC/TATCCCACTAATTTCACCC |
|
| Ubiquitin 7 | GAAGGCATTCCACCTGACCAAC/CTTGACCTTCTTCTTCTTGTGCTT |
Statistics of callus differentiation rate of cotton YZ-1.
|
|
|
|
|
|---|---|---|---|
| IAA | 0.05 | 0.1 | 70.83 |
| IAA | 0.025 | 0.1 | 42.86 |
| 2,4-D | 0.05 | 0.1 | 33.82 |
| 2,4-D | 0.025 | 0.1 | 19.44 |
| – | 0 | 0.1 | 7.81 |
Figure 1The number of upregulated and down-regulated DEGs was compared between samples. IAA, indole acetic acid; 24D, 2,4-dichlorophenoxyacetic acid; C0, 0 mg L−1; C1, 0.025 mg L−1; C2, 0.05 mg L−1; 5D, 5 days' treatment; 20D, 20 days' treatment.
Summary of annotated genes in each database of the pairwise comparisons.
|
|
|
|
|
|---|---|---|---|
| IAA-C1-5D VS IAA-C1-20D | 1,347 | 943 | 327 |
| IAA-C2-5D VS IAA-C2-20D | 2,369 | 1,640 | 587 |
| 24D-C1-5D VS 24 D-C1-20D | 2,865 | 2,006 | 748 |
| 24D-C2-5D VS 24D-C2-20D | 465 | 323 | 99 |
| C0-5D VS C0-20D | 4,118 | 2,785 | 1,191 |
| IAA-C1-5D VS IAA-C2-5D | 284 | 216 | 105 |
| IAA-C1-20D VS IAA-C2-20D | 384 | 242 | 96 |
| 24D-C1-5D VS 24D-C2-5D | 4,154 | 2,858 | 994 |
| 24D-C1-20D VS 24D-C2-20D | 5,530 | 3,789 | 1,296 |
| C0-5D VS IAA-C1-5D | 1,742 | 1,197 | 362 |
| C0-5D VS IAA-C2-5D | 1,823 | 1,280 | 474 |
| C0-5D VS 24D-C1-5D | 2,604 | 1,813 | 682 |
| C0-5D VS 24D-C2-5D | 1,204 | 795 | 294 |
| C0-20D VS IAA-C1-20D | 4,021 | 2,787 | 1,140 |
| C0-20D VS IAA-C2-20D | 3,275 | 2,250 | 1,005 |
| C0-20D VS 24D-C1-20D | 8,627 | 5,756 | 2,387 |
| C0-20D VS 24D-C2-20D | 7,543 | 5,110 | 2,065 |
| IAA-C1-5D VS 24D-C1-5D | 3,424 | 2,436 | 826 |
| IAA-C1-20D VS 24D-C1-20D | 5,252 | 3,563 | 1,318 |
| IAA-C2-5D VS 24D-C2-5D | 785 | 513 | 170 |
| IAA-C2-20D VS 24D-C2-20D | 3,606 | 2,461 | 832 |
IAA, indole acetic acid; 24D, 2,4-dichlorophenoxyacetic acid; C0, 0 mg L.
Figure 2Venn diagram of DEGs between different comparison groups. (A) C3 was compared with 0.025 mg L−1 of IAA at 5 days. (B) C3 was compared with different concentrations of 2,4-D. IAA, indole acetic acid; 24D, 2,4-dichlorophenoxyacetic acid; C0, 0 mg L−1; C1, 0.025 mg L−1; C2, 0.05 mg L−1; C3, 0.1 mg L−1; 5D, 5 days' treatment; 20D, 20 days' treatment.
Figure 3Histogram of GO enrichment of DEGs from samples treated with different auxin concentrations. (A) Enriched GO terms in C0-5D vs. IAA-C1-5D; (B) Enriched GO terms in C0-5D vs. IAA-C2-5D; (C) Enriched GO terms in C0-5D vs. 24D-C1-5D; (D) Enriched GO terms in C0-5D vs. 24D-C2-5D. IAA, indole acetic acid; 24D, 2,4-dichlorophenoxyacetic acid; C0, 0 mg L−1; C1, 0.025 mg L−1; C2, 0.05 mg L−1; 5D, 5 days' treatment.
Figure 4The KEGG enrichment of DEGs in comparison groups under the IAA induction effect. (A) Pathways enriched in C0-5D vs. IAA-C2-5D; (B) Pathways enriched in C0-20D vs. IAA-C2-20D. IAA, indole acetic acid; C0, 0 mg L−1; C2, 0.05 mg L−1; 5D, 5 days' treatment; 20D, 20 days' treatment.
Figure 5The KEGG enrichment of DEGs in comparison groups under the IAA dose effect. (A) Pathways enriched in C0-5D vs. IAA-C1-5D; (B) Pathways enriched in IAA-C1-5D vs. IAA-C2-5D; (C) Pathways enriched in C0-20D vs. IAA-C1-20D; and (D) Pathways enriched in IAA-C1-20D vs. IAA-C2-20D. IAA, indole acetic acid; 24D, 2,4-dichlorophenoxyacetic acid; C0, 0 mg L−1; C1, 0.025 mg L−1; C2, 0.05 mg L−1; 5D, 5 days' treatment; 20D, 20 days' treatment.
Representative DEGs induced by IAA.
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| Gh_A01G1294 |
| photosystem II core complex proteins psbY, chloroplastic | photosynthesis | −1.21 | C0-5D-VS-IAA-C2-5D |
| Gh_A08G1679 |
| photosystem II reaction center W protein, chloroplastic-like | photosynthesis | −1.11 | C0-5D-VS-IAA-C2-5D |
| Gh_D06G0548 |
| cytochrome P450 734A1-like | Brassinosteroid biosynthesis | −1.07 | C0-5D-VS-IAA-C2-5D |
| Gh_A07G2172 |
| ribulose bisphosphate carboxylase small chain, chloroplastic isoform X1 | Carbon metabolism | −3.64 | C0-20D-VS-IAA-C2-20D |
| Gh_A05G1647 |
| dihydroflavonol-4-reductase-like | Flavonoid biosynthesis | −1.01 | C0-20D-VS-IAA-C2-20D |
| Gh_A01G1563 |
| 3-ketoacyl-CoA synthase 6 | Fatty acid elongation | 2.43 | C0-20D-VS-IAA-C2-20D |
| Gh_A09G1415 |
| peroxidase 21 | Phenylpropanoid biosynthesis | −2.02 | C0-5D-VS-IAA-C1-5D |
| Gh_D08G0829 |
| peroxidase 73 | Phenylpropanoid biosynthesis | −1.93 | C0-5D-VS-IAA-C1-5D |
| Gh_D12G1798 |
| Flavonoid 3′-monooxygenase | Flavonoid biosynthesis | −1.06 | C0-5D-VS-IAA-C1-5D |
| Gh_Sca006141G01 |
| Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta, chloroplastic | Pyruvate metabolism | −1.77 | C0-5D-VS-IAA-C1-5D |
| Gh_A01G1681 |
| cytochrome P450 98A2-like | Flavonoid biosynthesis | −1.2 | C0-20D-VS-IAA-C1-20D |
| Gh_D11G1768 |
| ferredoxin–NADP reductase, leaf isozyme, chloroplastic | photosynthesis | −2.75 | C0-20D-VS-IAA-C1-20D |
| Gh_A01G1598 |
| photosystem II 22 kDa protein, chloroplastic-like | photosynthesis | −2.64 | C0-20D-VS-IAA-C1-20D |
| Gh_D07G2129 |
| photosystem II reaction center W protein, chloroplastic-like | photosynthesis | −2.81 | C0-20D-VS-IAA-C1-20D |
| Gh_A10G0948 |
| pyruvate, phosphate dikinase, chloroplastic | Carbon metabolism | −1.26 | IAA-C1-5D-VS-IAA-C2-5D |
| Gh_A10G2288 |
| peroxidase 27-like | Phenylpropanoid biosynthesis | −2.2 | IAA-C1-5D-VS-IAA-C2-5D |
| Gh_D08G0829 |
| peroxidase 59 | Phenylpropanoid biosynthesis | 2.18 | IAA-C1-20D-VS-IAA-C2-20D |
| Gh_A01G0158 |
| somatic embryogenesis receptor kinase 2-like isoform X1 | – | 1.34 | 24D-C3-0D-VS-C0-5D |
| Gh_A03G0840 |
| AP2/ERF and B3 domain-containing transcription factor RAV1-like | – | −1.19 | 24D-C3-0D-VS-IAA-C2-20D |
| Gh_D11G3261 |
| WUSCHEL-related homeobox 8-like | – | 2.85 | 24D-C3-0D-VS-IAA-C1-5D |
| Gh_A11G0358 |
| auxin response factor 2 isoform X1 | – | 1.19 | 24D-C3-0D-VS-IAA-C1-5D |
| Gh_A01G0908 |
| auxin response factor 5 isoform X1 | – | 1.68 | 24D-C3-0D-VS-IAA-C1-5D |
| Gh_A12G0504 |
| non-specific lipid-transfer protein 2 | – | 1.34 | 24D-C3-0D-VS-IAA-C1-5D |
IAA, indole acetic acid; 24D, 2,4-dichlorophenoxyacetic acid; C0, 0 mg L.
Figure 6The KEGG enrichment of DEGs in comparison groups under the 2,4-D induction effect. (A) Pathways enriched in C0-5D vs. 24D-C2-5D; (B) Pathways enriched in C0-20D vs. 24D-C2-20D. 24D, 2,4-dichlorophenoxyacetic acid; C0, 0 mg L−1; C2, 0.05 mg L−1; 5D, 5 days' treatment; 20D, 20 days' treatment.
Figure 7The KEGG enrichment of DEGs in comparison groups under 2,4-D dose effect. (A) Pathways enriched in C0-5D vs. 24D-C1-5D; (B) Pathways enriched in 24D-C1-5D vs. 24D-C2-5D; (C) Pathways enriched in C0-20D vs. 24D-C1-20D; (D) Pathways enriched in 24D-C1-20D vs. 24D-C2-20D. 24D, 2,4-dichlorophenoxyacetic acid; C0, 0 mg L−1; C1, 0.025 mg L−1; C2, 0.05 mg L−1; 5D, 5 days' treatment; 20D, 20 days' treatment.
Representative DEGs induced by 2,4-D.
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| Gh_D05G1217 |
| auxin-induced protein AUX22 | plant hormone signal transduction | 1.46 | C0-5D-VS-24D-C2-5D |
| Gh_A01G1955 |
| auxin transporter-like protein 2 | plant hormone signal transduction | 1.08 | C0-5D-VS-24D-C2-5D |
| Gh_D08G2503 |
| auxin-responsive protein IAA1-like | plant hormone signal transduction | 1.43 | C0-5D-VS-24D-C2-5D |
| Gh_D06G1764 |
| abscisic acid receptor PYL4-like | plant hormone signal transduction | −1.24 | C0-5D-VS-24D-C2-5D |
| Gh_A11G0443 |
| probable indole-3-acetic acid-amido synthetase GH3.1 | plant hormone signal transduction | 1.41 | C0-5D-VS-24D-C2-5D |
| Gh_A12G2619 |
| uncharacterized protein LOC105764246 | plant hormone signal transduction | −1.47 | C0-5D-VS-24D-C2-5D |
| Gh_D06G0548 |
| cytochrome P450 734A1-like | Brassinosteroid biosynthesis | −1.65 | C0-5D-VS-24D-C2-5D |
| Gh_D09G0130 |
| probable calcium-binding protein CML45 | Calcium signaling pathway | 1.66 | C0-5D-VS-24D-C2-5D |
| Gh_A10G0948 |
| pyruvate, phosphate dikinase, chloroplastic | Carbon metabolism | 1.42 | C0-20D-VS-24D-C2-20D |
| Gh_A01G1294 |
| photosystem II core complex proteins psbY, chloroplastic | photosynthesis | −2.51 | C0-20D-VS-24D-C2-20D |
| Gh_A08G1679 |
| photosystem II reaction center W protein, chloroplastic-like | photosynthesis | −1.69 | C0-20D-VS-24D-C2-20D |
| Gh_A01G1527 |
| long chain acyl-CoA synthetase 2 isoform X2 | Fatty acid biosynthesis | −4.73 | C0-5D-VS-24D-C1-5D |
| Gh_Sca006141G01 |
| Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta, chloroplastic | Fatty acid biosynthesis | −2.01 | C0-5D-VS-24D-C1-5D |
| Gh_A05G3293 |
| hypothetical protein B456_012G039400 | Photosynthesis | 1.01 | C0-5D-VS-24D-C1-5D |
| Gh_D12G0245 |
| ferredoxin-2-like | Photosynthesis | 1.61 | C0-5D-VS-24D-C1-5D |
| Gh_D10G0167 |
| oxygen-evolving enhancer protein 3, chloroplastic | Photosynthesis | 1.13 | C0-5D-VS-24D-C1-5D |
| Gh_D12G0039 |
| photosystem I reaction center subunit II, chloroplastic | Photosynthesis | 1.82 | C0-5D-VS-24D-C1-5D |
| Gh_A01G1527 |
| long chain acyl-CoA synthetase 2 isoform X2 | Fatty acid biosynthesis | 4.87 | 24D-C1-5D-VS-24D-C2-5D |
| Gh_Sca006141G01 |
| Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta, chloroplastic | Fatty acid biosynthesis | 1.2 | 24D-C1-5D-VS-24D-C2-5D |
| Gh_A09G0137 |
| probable calcium-binding protein CML45 | Calcium signaling pathway | 2.06 | 24D-C1-5D-VS-24D-C2-5D |
| Gh_D07G1759 |
| ribulose bisphosphate carboxylase small chain, chloroplastic isoform X1 | Carbon metabolism | −2.17 | 24D-C1-5D-VS-24D-C2-5D |
| Gh_A07G1821 |
| cell division control protein 45 homolog | Cell cycle | 2.14 | C0-20D-VS-24D-C1-20D |
| Gh_D11G0102 |
| cell division cycle 20.2, cofactor of APC complex-like | Cell cycle | 1.64 | C0-20D-VS-24D-C1-20D |
| Gh_A01G1294 |
| photosystem II core complex proteins psbY, chloroplastic | photosynthesis | −2.8 | C0-20D-VS-24D-C1-20D |
| Gh_A08G1679 |
| photosystem II reaction center W protein, chloroplastic-like | photosynthesis | −1.95 | C0-20D-VS-24D-C1-20D |
| Gh_A06G1446 |
| cytochrome P450 82A3 | Brassinosteroid biosynthesis | 3.25 | C0-20D-VS-24D-C1-20D |
| Gh_D11G0606 |
| alcohol dehydrogenase 1 | Fatty acid degradation | 2.49 | 24D-C1-20D-VS-24D-C2-20D |
| Gh_A01G1563 |
| 3-ketoacyl-CoA synthase 6 | Fatty acid elongation | 4.07 | 24D-C1-20D-VS-24D-C2-20D |
| Gh_A05G0335 |
| calcineurin B-like protein 4 isoform X1 | Calcium signaling pathway | 1.48 | 24D-C1-5D-VS-24D-C2-5D |
| Gh_D05G0341 |
| auxin-binding protein ABP20-like | – | 1.45 | 24D-C1-5D-VS-24D-C2-5D |
| Gh_A12G0175 |
| somatic embryogenesis receptor kinase 2-like | – | 1.25 | 24D-C1-5D-VS-24D-C2-5D |
| Gh_A06G0222 |
| AP2-like ethylene-responsive transcription factor ANT | – | 1.65 | C0-5D-VS-24D-C1-5D |
| Gh_A11G0886 |
| auxin response factor 18-like isoform X2 | – | −1.94 | C0-5D-VS-24D-C1-5D |
| Gh_A06G2038 |
| auxin response factor 3-like isoform X1 | – | 1.27 | C0-5D-VS-24D-C1-5D |
| Gh_A05G1607 |
| auxin response factor 5 isoform X2 | – | 1.14 | C0-5D-VS-24D-C1-5D |
| Gh_A08G2008 |
| AP2-like ethylene-responsive transcription factor BBM | – | 1.61 | 24D-C3-0D-VS-24D-C1-20D |
| Gh_A01G0393 |
| AP2/ERF and B3 domain-containing transcription factor RAV1-like | – | 2.12 | 24D-C3-0D-VS-24D-C2-20D |
| Gh_D05G1962 |
| WUSCHEL-related homeobox 4-like | – | 2.31 | 24D-C3-0D-VS-24D-C1-5D |
| Gh_A07G1254 |
| auxin response factor 18 isoform X1 | – | −1.67 | 24D-C3-0D-VS-24D-C1-5D |
| Gh_D05G0755 |
| auxin response factor 4 isoform X1 | – | 4.31 | 24D-C3-0D-VS-24D-C1-5D |
| Gh_D12G2535 |
| non-specific lipid-transfer protein 2-like | – | 3.44 | 24D-C3-0D-VS-24D-C1-5D |
24D, 2,4-dichlorophenoxyacetic acid; C0, 0 mg L.
Figure 8Comparison and confirmation of the RNA-seq data with qRT-PCR. (A–F) Relative expression of DEGs selected by comparative transcriptome induced by IAA and 2,4-D. Bars represent SD, and gene abundance was calculated relative to the GhUB7 expression level. IAA, indole acetic acid; 24D, 2,4-dichlorophenoxyacetic acid; C0, 0 mg L−1; C1, 0.025 mg L−1; C2, 0.05 mg L−1; C3, 0.1 mg L−1; 5D, 5 days' treatment; 20D, 20 days' treatment.